Abstract
Autoimmune activities have been implicated in the pathogenesis of hypertension. High levels of autoantibodies against the second extracellular loop of α1-adrenoceptor (α1-AR autoantibody, α1-AA) are found in patients with hypertension, and α1-AA could exert a α1-AR agonist-like vasoconstrictive effect. However, whether the vasoconstrictive effect of α1-AA is enhanced in hypertension is unknown. Using aortic rings of spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto (WKY) rats, we observed the vasoconstrictive responses to α1-AA with phenylephrine (α1-AR agonist) as a positive control drug. Aortic nitrotyrosine levels were also measured by ELISA and immunohistochemistry. The results showed that the aortic constrictive responses to α1-AA and phenylephrine (both 1 nmol L−1−10 μmol L−1) were greater in SHR than in WKY rats. Endothelial denudation or L-NAME (a non-selective NOS inhibitor) (100 μmol L−1) increased α1-AA- or phenylephrine-induced vasoconstrictions both in SHR and WKY. However, selective iNOS inhibitor 1400W (10 μmol L−1) enhanced the α1-AA-induced aortic constriction in WKY, but not in SHR. The aortic nitrotyrosine level was significantly higher in SHR than WKY, as shown by both ELISA and immunohistochemistry. These results indicate that the vasoconstrictive response to α1-AA is enhanced in SHR, and this altered responsiveness is due to endothelial dysfunction and decreased NO bioavailability. The study suggests an important role of α1-AR autoimmunity in the pathogenesis and management of hypertension especially in those harboring high α1-AA levels.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet, 2005, 365: 217–223
Dzielak DJ. The immune system and hypertension. Hypertension, 1992, 19: I36–I44
Fu ML. Do immune system changes have a role in hypertension? J Hypertens, 1995, 13: 1259–1265
Fu ML, Herlitz H, Wallukat G, Hilme E, Hedner T, Hoebeke J, Hjalmarson A. Functional autoimmune epitope on alpha1-adrenergic receptors in patients with malignant hypertension. Lancet, 1994, 344: 1660–1663
Luther HP, Homuth V, Wallukat G. Alpha1-adrenergic receptor antibodies in patients with primary hypertension. Hypertension, 1997, 29: 678–682
Wenzel K, Haase H, Wallukat G, Derer W, Bartel S, Homuth V, Herse F, Hubner N, Schulz H, Janczikowski M, Lindschau C, Schroeder C, Verlohren S, Morano I, Muller DN, Luft FC, Dietz R, Dechend R, Karczewski P. Potential relevance of α1-adrenergic receptor autoantibodies in refractory hypertension. PLoS ONE, 2008, 3: e3742
Yan L, Xu Y, Yao H, Xue W, Tian J, Ren H, Wu Y, Yang G, Ma XL, Liu H. The effects of autoantibodies against the second extracellular loop of alpha1-adrenoceptor on vasoconstriction. Basic Res Cardiol, 2009, 104: 581–589
Ibarra M, López-Guerrero JJ, Mejía-Zepeda R, Villalobos-Molina R. Endothelium-dependent inhibition of the contractile response is decreased in aorta from aged and spontaneously hypertensive rats. Arch Med Res, 2006, 37: 334–341
Linder L, Kiowski W, Bühler FR, Lüscher TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo: blunted response in essential hypertension. Circulation, 1990, 81: 1762–1767
Panza JA, García CE, Kilcoyne CM, Quyyumi AA, Cannon RO 3rd. Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation, 1995, 91: 1732–1738
Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med, 1990, 323: 22–27
Guimarães S, Moura D. Vascular adrenoceptors: an update. Pharmacol Rev, 2001, 53: 319–356
Li J, Cao YX, Liu H, Xu CB. Enhanced G-protein coupled receptors-mediated contraction and reduced endothelium-dependent relaxation in hypertension. Eur J Pharmacol, 2007, 28: 186–194
Behrendt D, Ganz P. Endothelial function: from vascular biology to clinical applications. Am J Cardiol, 2002, 90: 40L–48L
Lüscher TF, Boulanger CM, Yang Z, Noll G, Dohi Y. Interactions between endothelium derived relaxing and contracting factors in health and cardiovascular disease. Circulation, 1993, 87(Suppl V): 36–44
Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev, 1991, 43: 109–142
Bullock GR, Taylor SG, Weston AH. Influence of the vascular endothelium on agonist-induced contractions and relaxations in rat aorta. Br J Pharmacol, 1986, 89: 819–830
Criscione L, Müller K, Forney Prescott M. Endothelial cell loss enhances the pressor response in resistance vessels. J Hypertens, 1984, 2: S441–S444
Eglème C, Godfraind T, Miller RC. Enhanced responsiveness of rat isolated aorta to clonidine after removal of the endothelial cell. Br J Pharmacol, 1984, 81: 16–18
Martin W, Furchgott RF, Villani GM, Jothianandan D. Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor. J Pharmacol Exp Ther, 1986, 237: 529–538
Yamaguchi T, Rodman D, O’Brien R, McMurtry I. Modulation of pulmonary artery contraction by endothelium-derived relaxing factor. Eur J Pharmacol, 1989, 161: 259–262
Alvarez Y, Briones AM, Hernanz R, Pérez-Girón JV, Alonso MJ, Salaices M. Role of NADPH oxidase and iNOS in vasoconstrictor responses of vessels from hypertensive and normotensive rats. Br J Pharmacol, 2008, 153: 926–935
Félétou M, Vanhoutte PM. Endothelial dysfunction: a multifaceted disorder. Am J Physiol Heart Circ Physiol, 2006, 291: H985–H1002
Förstermann U, Closs EI, Pollock JS, Nakane M, Schwarz P, Gath I, Kleinert H. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension, 1994, 23: 1121–1131
Ridnour LA, Thomas DD, Mancardi D, Espey MG, Miranda KM, Paolocci N, Feelisch M, Fukuto J, Wink DA. The chemistry of nitrosative stress induced by nitric oxide and reactive nitrogen oxide species. Putting perspective on stressful biological situations. Biol Chem, 2004, 385: 1–10
Upmacis RK, Crabtree MJ, Deeb RS, Shen H, Lane PB, Benguigui LE, Maeda N, Hajjar DP, Gross SS. Profound biopterin oxidation and protein tyrosine nitration in tissues of ApoE-null mice on an atherogenic diet: contribution of inducible nitric oxide synthase. Am J Physiol Heart Circ Physiol, 2007, 293: H2878–H2887
Förstermann U, Li H. Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling. Br J Pharmacol, 2011, 164: 213–223
Liu HR, Zhao RR, Zhi JM, Wu BW, Fu ML. Screening of serum autoantibodies to cardiac β1-adrenoceptors and M2-muscarinic acetylcholine receptors in 408 healthy subjects of varying ages. Autoimmunity, 1999, 29: 43–51
Porstmann T, Kiessig ST. Enzyme immunoassay techniques-an overview. J Immunol Methods, 1992, 150: 5–21
Tao L, Liu HR, Gao F, Qu Y, Christopher TA, Lopez BL, Ma XL. Mechanical traumatic injury without circulatory shock causes cardiomyocyte apoptosis: role of reactive nitrogen and reactive oxygen species. Am J Physiol Heart Circ Physiol, 2005, 288: H2811–H2818
Alvarez Y, Briones AM, Balfagón G, Alonso MJ, Salaices M. Hypertension increases the participation of vasoconstrictor prostanoids from cyclooxygenase-2 in phenylephrine responses. J Hypertens, 2005, 23: 767–777
Alvarez Y, Pérez-Girón JV, Hernanz R, Briones AM, García-Redondo A, Beltrán A, Alonso MJ, Salaices M. Losartan reduces the increased participation of COX-2 derived products in vascular responses of hypertensive rats. J Pharmacol Exp Ther, 2007, 321: 381–388
Fu ML, Wallukat G, Hjalmarson A, Hoebeke J. Characterization of anti-peptide antibodies directed against an extracellular immunogenic epitope on the human α1-adrenergic receptor. Clin Exp Immunol, 1994, 97: 146–151
Bkaily G, EI-Bizri N, Bui M, Sukarieh R, Jacques D, Fu ML. Modulation of intracellular Ca2+ via L-type calcium channels in heart cells by the autoantibody directed against the second extracellular loop of the alpha1-adrenoceptors. Can J Physiol Pharmacol, 2003, 81: 234–246
Dora KA, Hinton JM, Walker SD, Garland CJ. An indirect influence of phenylephrine on the release of endothelium-derived vasodilators in rat small mesenteric artery. Br J Pharmacol, 2000, 129: 381–387
Nishina H, Ozaki T, Hanson MA, Poston L. Mechanism of noradrenaline-induced vasorelaxation in isolated femoral arteries of the neonatal rat. Br J Pharmacol, 1999, 127: 809–812
Mendez E, Calzada C, Ocharan E, Sierra A, Castillo C, Ramirez I, Meaney E, Meaney A, Asbun J, Miliar A, Herrera J, Ceballos G. Differential expression of alpha1-adrenergic receptor subtypes in coronary microvascular endothelial cells in culture. Eur J Pharmacol, 2006, 546: 127–133
Briones AM, Alonso MJ, Hernanz R, Miguel M, Salaices M. Alterations of the nitric oxide pathway in cerebral arteries from spontaneously hypertensive rats. J Cardiovasc Pharmacol, 2002, 39: 378–388
Vaziri ND, Ni Z, Oveisi F. Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats. Hypertension, 1998, 31: 1248–1254
Rees DD, Cellek S, Palmer RM, Moncada S. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem Biophys Res Commun, 1990, 173: 541–547
Alonso MJ, Rodríguez-Martínez MA, Martínez-Orgado J, Marín J, Salaices M. The L-arginine inhibition of rat middle cerebral artery contractile responses is mediated by inducible nitric oxide synthase. J Auton Pharmacol, 1998, 18: 105–113
Author information
Authors and Affiliations
Corresponding authors
Additional information
Contributed equally to this work
This article is published with open access at link.springer.com
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Yan, L., Tan, X., Chen, W. et al. Enhanced vasoconstriction to α1 adrenoceptor autoantibody in spontaneously hypertensive rats. Sci. China Life Sci. 57, 681–689 (2014). https://doi.org/10.1007/s11427-014-4672-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-014-4672-8